IADR Abstract Archives
Arnica montana in reducing edema following third molar extraction
Objectives: Surgical removal of impacted third molars results in tissue trauma and produces an inflammatory response that is most often accompanied by severe pain. Patients often complain of postoperative pain, trismus, swelling, and dysphagia following the extraction of third molars, especially in cases of surgical exposure. The prescribing of oral analgesics is standard care for the treatment of postoperative pain for at least 24 hours following third molar extraction. However, no medications are given specifically for management of facial swelling following this surgery. The overall objective of this study is study is to compare differences in the postoperative edema and pain following third molar extraction experienced by subjects who were treated with perioperative homeopathic Arnica montana versus subjects who received matching placebo.
Methods: A randomized double-blinded study is being conducted to evaluate the use of Arnica Montana in management of pain and swelling following impacted third molar removal. The study involves 70 patients in two groups (35 patients each) from ages 18 to 40 with an ASA I or II classification. All patients will have routine, non-emergent, third molar surgery under IV sedation or General Anesthesia by one of two surgeons of equivalent training at the same institution. The dosing of study medication is as follows: 1 capsule or placebo (preoperative dose #1) is taken orally 1 hours before surgery, 1 postoperative dose just prior to discharge, 1 dose before bedtime, 1 capsule is taken orally thrice daily for 3 days after surgery. Swelling was measured at baseline, Day 3 and Day 7 using 3DMD imaging software.Pain was measured using a Visual Analog Scale (VAS)
Results: The investigators are blinded to the study medications so the results are not available at this time for this ongoing clinical trial.
Conclusions: It is our anticipation that A.Montana will aid in reducing postoperative swelling and pain following third moalr extractions.The implications of the result of this study will be significant since there are very few clinical studies looking at the efficacy of complementary therapeutic options in dentistry.
Methods: A randomized double-blinded study is being conducted to evaluate the use of Arnica Montana in management of pain and swelling following impacted third molar removal. The study involves 70 patients in two groups (35 patients each) from ages 18 to 40 with an ASA I or II classification. All patients will have routine, non-emergent, third molar surgery under IV sedation or General Anesthesia by one of two surgeons of equivalent training at the same institution. The dosing of study medication is as follows: 1 capsule or placebo (preoperative dose #1) is taken orally 1 hours before surgery, 1 postoperative dose just prior to discharge, 1 dose before bedtime, 1 capsule is taken orally thrice daily for 3 days after surgery. Swelling was measured at baseline, Day 3 and Day 7 using 3DMD imaging software.Pain was measured using a Visual Analog Scale (VAS)
Results: The investigators are blinded to the study medications so the results are not available at this time for this ongoing clinical trial.
Conclusions: It is our anticipation that A.Montana will aid in reducing postoperative swelling and pain following third moalr extractions.The implications of the result of this study will be significant since there are very few clinical studies looking at the efficacy of complementary therapeutic options in dentistry.